Francisco Esteva: Impact of COVID-19 on healthcare services
Francisco Esteva, Chief of the Division of Hematology and Medical Oncology at Lenox Hill Hospital, shared a post on LinkedIn about a recent paper by Nadia Howlader et al. published in Journal of the National Cancer Institute.
“Impact of COVID-19 on 2021 cancer incidence rates and potential rebound from 2020 decline”
Authors: Nadia Howlader, Huann-Sheng Chen, Anne-Michelle Noone, Daniel Miller, Jeffry Byrne, Serban Negoita, Kathleen Cronin, Angela Mariotto.
“The COVID-19 pandemic led to a significant drop in cancer cases in 2020 because of interruptions in screening and diagnostic services.
A recent study looked at data from 22 cancer registries and found that while some cancers, like pancreatic cancer, almost returned to pre-pandemic levels in 2021, others, like thyroid cancer, had mixed recovery rates depending on the stage. Metastatic breast cancer showed significantly higher observed rates than expected.
These results highlight the ongoing impact of the pandemic on healthcare services and show the need for continuous monitoring and adjustments in cancer care. Making sure we have strong screening and diagnostic services is critical to address the long-term effects on cancer outcomes.”
Source: Francisco Esteva/LinkedIn
More posts featuring Francisco Esteva on oncodaily.com
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023